Early ART Initiation in West Africa has no Adverse Social Consequences: A 24-Month Prospective Study

Kévin Jean (1) , Serge Niangoran (2) , Christine Danel (3, 2) , Raoul Moh (2) , Gérard Kouamé Menan (2) , Anani Badjé (3, 2) , Delphine Gabillard (3) , Serge Eholié (2) , Rosemary Dray-Spira (4) , France Lert (1) , Xavier Anglaret (3, 2) , Annabel Desgrées-Du-Loû (5)

1 CESP - Centre de recherche en épidémiologie et santé des populations
2 CHU - Centre Hospitalier Universitaire [Treichville]
3 SISTM - Statistics In System biology and Translational Medicine
4 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
5 CEPED - UMR_D 196 - Centre population et développement

Based on social indicators collected within the TEMPRANO-ANRS12136 trial, we assessed the social consequences of early antiretroviral therapy (ART) initiation in west Africa. We did not observe any significant differences in the levels or the time trends of various social indicators, including union status, HIV disclosure and HIV-related discrimination, between early and deferred ART initiation. Early ART does not carry detectable adverse social consequences that could impair its clinical and preventive benefits.

Domaines: Santé publique et épidémiologie

Kévin Jean, Serge Niangoran, Christine Danel, Raoul Moh, Gérard Kouamé Menan, et al.. Early ART Initiation in West Africa has no Adverse Social Consequences: A 24-Month Prospective Study. AIDS. Official journal of the international AIDS Society, 2016. ⟨hal-01351764⟩